National Health Investors (NYSE:NHI) CEO D. Eric Mendelsohn Acquires 1,500 Shares

National Health Investors, Inc. (NYSE:NHI) CEO D. Eric Mendelsohn acquired 1,500 shares of the stock in a transaction on Friday, June 5th. The shares were purchased at an average cost of $68.84 per share, with a total value of $103,260.00. Following the transaction, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

National Health Investors Stock Performance

Shares of National Health Investors stock opened at $70.35 on Friday. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $3.41 billion, a P/E ratio of 22.69, a P/E/G ratio of 3.56 and a beta of 0.52. The business has a fifty day simple moving average of $78.33 and a two-hundred day simple moving average of $80.31. National Health Investors, Inc. has a 12 month low of $67.94 and a 12 month high of $91.38.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.39). The firm had revenue of $115.13 million for the quarter, compared to analysts’ expectations of $70.22 million. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The business’s quarterly revenue was up 28.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.15 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities analysts forecast that National Health Investors, Inc. will post 5.07 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 5.2%. National Health Investors’s dividend payout ratio (DPR) is currently 118.71%.

Hedge Funds Weigh In On National Health Investors

Several institutional investors and hedge funds have recently modified their holdings of NHI. International Assets Investment Management LLC bought a new position in shares of National Health Investors during the fourth quarter valued at $27,000. EverSource Wealth Advisors LLC increased its holdings in shares of National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new position in shares of National Health Investors during the fourth quarter valued at $33,000. GAMMA Investing LLC increased its holdings in shares of National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 136 shares in the last quarter. Finally, Key Capital Management INC bought a new position in shares of National Health Investors during the fourth quarter valued at $47,000. 62.51% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

NHI has been the subject of several recent research reports. Wells Fargo & Company lowered their price objective on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research report on Friday, March 27th. Cantor Fitzgerald reissued an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. Finally, Truist Financial reduced their price target on National Health Investors from $92.00 to $89.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, National Health Investors currently has an average rating of “Moderate Buy” and an average target price of $86.67.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.